The Translational Role of MiRNA in Polycystic Ovary Syndrome: From Bench to Bedside-A Systematic Literature Review

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Aug 26

PMID 36009364

Authors

Salvatore Giovanni Vitale

Anna Maria Fulghesu

Mislav Mikus

Rafal Watrowski

Maurizio Nicola DAlterio

Li-Te Lin

Mohsin Shah

Enrique Reyes-Munoz

Thozhukat Sathyapalan

Stefano Angioni

Affiliations

Soon will be listed here.

Abstract

MicroRNAs (miRNAs) are small, non-coding RNAs that are essential for the regulation of post-transcriptional gene expression during tissue development and differentiation. They are involved in the regulation of manifold metabolic and hormonal processes and, within the female reproductive tract, in oocyte maturation and folliculogenesis. Altered miRNA levels have been observed in oncological and inflammatory diseases, diabetes or polycystic ovary syndrome (PCOS). Therefore, miRNAs are proving to be promising potential biomarkers. In women with PCOS, circulating miRNAs can be obtained from whole blood, serum, plasma, urine, and follicular fluid. Our systematic review summarizes data from 2010-2021 on miRNA expression in granulosa and theca cells; the relationship between miRNAs, hormonal changes, glucose and lipid metabolism in women with PCOS; and the potential role of altered miRNAs in fertility (oocyte quality) in PCOS. Furthermore, we discuss miRNAs as a potential therapeutic target in PCOS and as a diagnostic marker for PCOS.

Citing Articles

Ultrasound Assessment in Polycystic Ovary Syndrome Diagnosis: From Origins to Future Perspectives-A Comprehensive Review.

Di Michele S, Fulghesu A, Pittui E, Cordella M, Sicilia G, Mandurino G Biomedicines. 2025; 13(2).

PMID: 40002866 PMC: 11853298. DOI: 10.3390/biomedicines13020453.

Decreased Serum Levels of the Insulin Resistance-Related microRNA miR-320a in Patients with Polycystic Ovary Syndrome.

Vogt S, Handke D, Behre H, Greither T Curr Issues Mol Biol. 2024; 46(4):3379-3393.

PMID: 38666942 PMC: 11049427. DOI: 10.3390/cimb46040212.

Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s.

Etrusco A, Mikus M, Damato A, Barra F, Planinic P, Goluza T Biomedicines. 2024; 12(3).

PMID: 38540265 PMC: 10967775. DOI: 10.3390/biomedicines12030653.

Circulating miRNAs and Preeclampsia: From Implantation to Epigenetics.

Giannubilo S, Cecati M, Marzioni D, Ciavattini A Int J Mol Sci. 2024; 25(3).

PMID: 38338700 PMC: 10855731. DOI: 10.3390/ijms25031418.

miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery.

Rashid G, Khan N, Elsori D, Youness R, Hassan H, Siwan D Arch Gynecol Obstet. 2024; 309(5):1707-1723.

PMID: 38316651 DOI: 10.1007/s00404-024-07379-4.

References

Song J, Luo S, Li S . miRNA-592 is downregulated and may target LHCGR in polycystic ovary syndrome patients. Reprod Biol. 2015; 15(4):229-37. DOI: 10.1016/j.repbio.2015.10.005. View

Sorensen A, Udesen P, Wissing M, Englund A, Dalgaard L . MicroRNAs related to androgen metabolism and polycystic ovary syndrome. Chem Biol Interact. 2016; 259(Pt A):8-16. DOI: 10.1016/j.cbi.2016.06.008. View

Scalici E, Traver S, Mullet T, Molinari N, Ferrieres A, Brunet C . Circulating microRNAs in follicular fluid, powerful tools to explore in vitro fertilization process. Sci Rep. 2016; 6:24976. PMC: 4840336. DOI: 10.1038/srep24976. View

Gay S, Bugeon J, Bouchareb A, Henry L, Delahaye C, Legeai F . MiR-202 controls female fecundity by regulating medaka oogenesis. PLoS Genet. 2018; 14(9):e1007593. PMC: 6147661. DOI: 10.1371/journal.pgen.1007593. View

Jiang L, Huang J, Li L, Chen Y, Chen X, Zhao X . MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome. J Clin Endocrinol Metab. 2015; 100(5):E729-38. PMC: 4422895. DOI: 10.1210/jc.2014-3827. View

Capuani B, Pacifici F, Della-Morte D, Lauro D . Glucagon Like Peptide 1 and MicroRNA in Metabolic Diseases: Focusing on GLP1 Action on miRNAs. Front Endocrinol (Lausanne). 2018; 9:719. PMC: 6293193. DOI: 10.3389/fendo.2018.00719. View

Karolina D, Armugam A, Tavintharan S, Wong M, Lim S, Sum C . MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One. 2011; 6(8):e22839. PMC: 3148231. DOI: 10.1371/journal.pone.0022839. View

Zhao C, Liu X, Shi Z, Zhang J, Zhang J, Jia X . Role of serum miRNAs in the prediction of ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients. Cell Physiol Biochem. 2015; 35(3):1086-94. DOI: 10.1159/000373934. View

Lin L, Du T, Huang J, Huang L, Yang D . Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance. Chin Med J (Engl). 2015; 128(2):169-74. PMC: 4837833. DOI: 10.4103/0366-6999.149189. View

10.

Deswal R, Dang A . Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2020; 113(3):661-669.e2. DOI: 10.1016/j.fertnstert.2019.11.001. View

11.

Carthew R, Sontheimer E . Origins and Mechanisms of miRNAs and siRNAs. Cell. 2009; 136(4):642-55. PMC: 2675692. DOI: 10.1016/j.cell.2009.01.035. View

12.

Hou Y, Wang Y, Xu S, Qi G, Wu X . Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data. Mol Med Rep. 2019; 20(1):281-291. PMC: 6579986. DOI: 10.3892/mmr.2019.10253. View

13.

Tu J, Cheung A, Chan C, Chan W . The Role of microRNAs in Ovarian Granulosa Cells in Health and Disease. Front Endocrinol (Lausanne). 2019; 10:174. PMC: 6437095. DOI: 10.3389/fendo.2019.00174. View

14.

Zhou Y, Liu J, Lei Q, Han H, Liu W, Cunwei T . Transcriptome Analysis of the Chicken Follicular Theca Cells with miR-135a-5p Suppressed. G3 (Bethesda). 2020; 10(11):4071-4081. PMC: 7642930. DOI: 10.1534/g3.120.401701. View

15.

Abdalla M, Deshmukh H, Atkin S, Sathyapalan T . miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review. Life Sci. 2020; 259:118174. DOI: 10.1016/j.lfs.2020.118174. View

16.

Sorensen A, Wissing M, Englund A, Dalgaard L . MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes. J Clin Endocrinol Metab. 2016; 101(4):1579-89. PMC: 4880172. DOI: 10.1210/jc.2015-3588. View

17.

Stadler J, Marsche G . Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function. Int J Mol Sci. 2020; 21(23). PMC: 7731239. DOI: 10.3390/ijms21238985. View

18.

Song Y, Yu G, Xiang Y, Li Y, Wan L, Tan L . Altered miR-186 and miR-135a contribute to granulosa cell dysfunction by targeting ESR2: A possible role in polycystic ovary syndrome. Mol Cell Endocrinol. 2019; 494:110478. DOI: 10.1016/j.mce.2019.110478. View

19.

Chadt A, Al-Hasani H . Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflugers Arch. 2020; 472(9):1273-1298. PMC: 7462924. DOI: 10.1007/s00424-020-02417-x. View

20.

Wu H, Heneidi S, Chuang T, Diamond M, Layman L, Azziz R . The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2014; 99(12):E2754-61. PMC: 4255124. DOI: 10.1210/jc.2013-4435. View